0.907
0.01 (0.78%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Imunon, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | 4.0 |
| Price Volatility | 2.2 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | -2.5 |
| Relative Valuation | NA |
| Financial Health | -4.9 |
| Macro Environment | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | 0.53 |
Select this tab to load the latest available analysis.
|
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body’s natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101). |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 5.19% |
| % Held by Institutions | 1.15% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Riverview Capital Advisers, Llc | 30 Jun 2026 | 34,364 |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| FALLER DOUGLAS VINCENT | 1.24 | - | 27,833 | 34,513 |
| LINDBORG STACY | 1.24 | - | 2,603 | 3,228 |
| TARDUGNO MICHAEL H | 1.24 | - | 6,821 | 8,458 |
| Aggregate Net Quantity | 37,257 | |||
| Aggregate Net Value ($) | 46,199 | |||
| Aggregate Avg. Buy ($) | 1.24 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| FALLER DOUGLAS VINCENT | Officer | 23 Oct 2026 | Acquired (+) | 27,833 | 1.24 | 34,513 |
| LINDBORG STACY | Officer | 23 Oct 2026 | Acquired (+) | 2,603 | 1.24 | 3,228 |
| TARDUGNO MICHAEL H | Officer | 23 Oct 2026 | Acquired (+) | 6,821 | 1.24 | 8,458 |
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |